These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 25892708)
1. Identifying the need for a multidisciplinary approach for early recognition of mucopolysaccharidosis VI (MPS VI). Choy YS; Bhattacharya K; Balasubramaniam S; Fietz M; Fu A; Inwood A; Jin DK; Kim OH; Kosuga M; Kwun YH; Lin HY; Lin SP; Mendelsohn NJ; Okuyama T; Samion H; Tan A; Tanaka A; Thamkunanon V; Thong MK; Toh TH; Yang AD; McGill J Mol Genet Metab; 2015 May; 115(1):41-7. PubMed ID: 25892708 [TBL] [Abstract][Full Text] [Related]
2. [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI]. Zheng J; Huang Y; Zhao X; Sheng H; Cheng J; Zhou Z; Li X; Mao X; Liu L Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):403-8. PubMed ID: 25190157 [TBL] [Abstract][Full Text] [Related]
3. Current diagnosis and management of mucopolysaccharidosis VI in the Asia-Pacific region. Hwu WL; Okuyama T; But WM; Estrada S; Gu X; Hui J; Kosuga M; Lin SP; Ngu LH; Shi H; Tanaka A; Thong MK; Wattanasirichaigoon D; Wasant P; McGill J Mol Genet Metab; 2012 Sep; 107(1-2):136-44. PubMed ID: 22864057 [TBL] [Abstract][Full Text] [Related]
4. Abnormal granulation of blood granulocytes in mucopolysaccharidosis VI-a case report. Krishnagiri C; Ajanahalli RR; Kashyap S; Anegundi R; Boranaik L Ann Diagn Pathol; 2013 Feb; 17(1):137-9. PubMed ID: 22056033 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome). Golda A; Jurecka A; Tylki-Szymanska A Int J Cardiol; 2012 Jun; 158(1):6-11. PubMed ID: 21737154 [TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy attenuates disease progression in two Japanese siblings with mucopolysaccharidosis type VI. Furujo M; Kubo T; Kosuga M; Okuyama T Mol Genet Metab; 2011 Dec; 104(4):597-602. PubMed ID: 21930407 [TBL] [Abstract][Full Text] [Related]
7. Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose. Lachman RS; Burton BK; Clarke LA; Hoffinger S; Ikegawa S; Jin DK; Kano H; Kim OH; Lampe C; Mendelsohn NJ; Shediac R; Tanpaiboon P; White KK Skeletal Radiol; 2014 Mar; 43(3):359-69. PubMed ID: 24389823 [TBL] [Abstract][Full Text] [Related]
9. Expert recommendations for the laboratory diagnosis of MPS VI. Wood T; Bodamer OA; Burin MG; D'Almeida V; Fietz M; Giugliani R; Hawley SM; Hendriksz CJ; Hwu WL; Ketteridge D; Lukacs Z; Mendelsohn NJ; Miller N; Pasquali M; Schenone A; Schoonderwoerd K; Winchester B; Harmatz P Mol Genet Metab; 2012 May; 106(1):73-82. PubMed ID: 22405600 [TBL] [Abstract][Full Text] [Related]
10. Attenuated osteoarticular phenotype of type VI mucopolysaccharidosis: a report of four patients and a review of the literature. Jurecka A; Zakharova E; Malinova V; Voskoboeva E; Tylki-Szymańska A Clin Rheumatol; 2014 May; 33(5):725-31. PubMed ID: 24221504 [TBL] [Abstract][Full Text] [Related]
11. Mucopolysaccharidosis type VI: a cardiologist's guide to diagnosis and treatment. Golda A; Jurecka A; Opoka-Winiarska V; Tylki-Szymańska A Int J Cardiol; 2013 Jul; 167(1):1-10. PubMed ID: 22704873 [TBL] [Abstract][Full Text] [Related]
14. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Harmatz P; Ketteridge D; Giugliani R; Guffon N; Teles EL; Miranda MC; Yu ZF; Swiedler SJ; Hopwood JJ; Pediatrics; 2005 Jun; 115(6):e681-9. PubMed ID: 15930196 [TBL] [Abstract][Full Text] [Related]